SAR mining and its application to the design of TRPA1 antagonists

Given the large amounts of screening data now available, empirical methods derived from matched-molecular pairs are being used as a means for suggesting bioisosteric replacements to the medicinal chemist. The pairwise analysis of compounds has been extended to the pairwise analysis of series to bring further context to these suggestions. A validation dataset derived from recent literature has been used to demonstrate that, given a series of active compounds, this approach would be expected to predict a more potent compound, if it exists, in around 46% of cases. The approach has been successfully applied to a series of TRPA1 antagonists.

[1]  P. Hajduk,et al.  Statistical analysis of the effects of common chemical substituents on ligand potency. , 2008, Journal of Medicinal Chemistry.

[2]  F. Lezoualc’h,et al.  New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms. , 2000, Journal of medicinal chemistry.

[3]  Pierangelo Geppetti,et al.  Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. , 2010, Journal of medicinal chemistry.

[4]  D. Zeng,et al.  The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma. , 2005, Bioorganic & medicinal chemistry letters.

[5]  C. Fanger.  TRPA1 as an Analgesic Target~!2010-01-18~!2010-03-10~!2010-07-26~! , 2010 .

[6]  J. Bajorath,et al.  Chemical transformations that yield compounds with distinct activity profiles. , 2011, ACS medicinal chemistry letters.

[7]  K. Stewart,et al.  Drug Guru: a computer software program for drug design using medicinal chemistry rules. , 2006, Bioorganic & medicinal chemistry.

[8]  J. Topliss,et al.  Utilization of operational schemes for analog synthesis in drug design. , 1972, Journal of medicinal chemistry.

[9]  Jing Sun,et al.  Comparative Study of Factor Xa Inhibitors Using Molecular Docking/SVM/HQSAR/3D-QSAR Methods , 2006 .

[10]  Pierre Bruneau,et al.  A Database of Historically-Observed Chemical Replacements , 2007, J. Chem. Inf. Model..

[11]  Visakan Kadirkamanathan,et al.  Lead Optimization Using Matched Molecular Pairs: Inclusion of Contextual Information for Enhanced Prediction of hERG Inhibition, Solubility, and Lipophilicity , 2010, J. Chem. Inf. Model..

[12]  Michael Devereux,et al.  Quantum Isostere Database: A Web-Based Tool Using Quantum Chemical Topology To Predict Bioisosteric Replacements for Drug Design , 2009, J. Chem. Inf. Model..

[13]  Anna Gaulton,et al.  Drug target central , 2009, Expert opinion on drug discovery.

[14]  J. Bajorath,et al.  Identification of target family directed bioisosteric replacements , 2011 .

[15]  Jameed Hussain,et al.  Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..

[16]  Mathias Wawer,et al.  Navigating structure-activity landscapes. , 2009, Drug discovery today.

[17]  Lyn H. Jones,et al.  Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry , 2010 .

[18]  Peter Ertl,et al.  Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization , 2010, Molecular informatics.

[19]  Daniel J. Warner,et al.  WizePairZ: A Novel Algorithm to Identify, Encode, and Exploit Matched Molecular Pairs with Unspecified Cores in Medicinal Chemistry , 2010, J. Chem. Inf. Model..

[20]  P. Popelier,et al.  In silico techniques for the identification of bioisosteric replacements for drug design. , 2010, Current topics in medicinal chemistry.